Seroba Kernel Life Sciences, the newly formed venture capital fund partnership, will plough investment funds of up to €7 million into as many as 15 companies in Britain and Ireland.
It will fund the investment from an initial pot of €75 million, targeting product-focused and innovative life science companies at early to mid-stage development. Seroba Kernel was one of four investors which last week announced a major €18 million investment in Dublin-based biotech Opsona Therapeutics.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team